Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1997-07-10
1999-03-02
Witz, Jean C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514 50, 514261, 424 852, A01N 4304, A01N 4390, A61K 4505
Patent
active
058771638
ABSTRACT:
A method of treating AIDS with 3'-azido-3'-deoxythymidine in combination with interleukin II or phosphonoformate is presented.
REFERENCES:
patent: 4724232 (1988-02-01), Rideout et al.
patent: 4857511 (1989-08-01), Rideout et al.
patent: 4874609 (1989-10-01), Rideout et al.
Antonella Surbone, M.D., "Treatment of the Acquired Immunodeficiency Syndrome (AIDS) and AIDS-Relatee Complex with a Regimen of 3'-Azido-2',3'-Dideoxythymidine (Azidothymidine or Zidovudine) and Acyclovir," Annals of Internal Medicine, 1988; 108: pp. 534-540.
Anthony W. Schrecker, "Inhibition of RNA-dependent DNA Polymerase by Thymidylate Derivatives.sup.1," Cancer Research, 32, pp. 1547-1553, July 1972.
Roland K. Robins, "Synthetic Antiviral Agents," Chem. Eng. News, vol. 64, N.R. 4, pp. 28-40, Jan. 27, 1986.
FDA Drug Bull., vol. 15, NR 3, Oct. 1985, pp. 27-32.
"Zidovudine (AZT)," The Lancet, NR 8539, Apr. 25, 1997, pp. 957-958.
Donald E. Riesenberg, MD, "Anti-AIDS agents show varying early results in vitro and in vivo," JAMA (Medical News) Nov. 8, 1995--vol. 254, No. 18.
Hiroaki Mitsuya, "3'-Azido-3'-deoxythymidine (BW A509U): An antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro," Proc. Natl. Acad. Sci USA, vol. 82, pp. 7096-7100, Oct. 1985.
Robert Yarchoan, et al., "Adminstration of 3'-Azido-3'-Deoxythymidine, an Inhibitor of HTLV-III/LAV Replication, to Patients With AIDS or AIDS-Related Complex," The Lancet, Mar. 15, 1986, pp. 575-580.
Craig et al. "Modern Pharmacology", 3rd efition. (1990) (Little, Brown and Co.: Boston) p. 385, 1990.
Barry David Walter
Furman Phillip Allen
Lehrman Sandra Nusinoff
Rideout Janet Litster
St. Clair Martha Heider
Glaxo Wellcome Inc.
Hanley Susan
Prus Karen L.
Witz Jean C.
LandOfFree
Treatment of human viral infections does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of human viral infections, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of human viral infections will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-423001